The management team of the Staffordshire-headquartered business, led by executive chairman Charles Walsh and Mike Gordon, will remain the majority shareholder. Walsh founded
Adrian Beecroft, senior managing partner of
The company now serves around 40,000 patients annually, and provides its services through two operational divisions, Speciality Pharma Services and Clinical Services.
Following the acquisition of his company by
Reports suggested that the company attracted interest from United Drugs, Alliance Boots, Celesio and Assura. Hutton Collins’ victory was welcomed by the firm’s founder, Graham Collins: “Healthcare at Home has a clear vision to improve the quality of life for thousands of patients across the UK and Hutton Collins looks forward to supporting the Company through its next stage of growth.”
Nomura International and Landsbanki Ireland HF acted as underwriters for the debt facilities of £175m, with Nomura International acting as bookrunner. Hutton Collins was advised by Investec, Eversheds, KPMG and Candesic. Healthcare at Home was advised by UBS Investment Bank.
The deal is Hutton Collins’ third investment of the year after buying a minority stake in Lloyd’s insurance broker Windsor, and backing the MBO of Everis Spain, an IT consultancy, from Apax Partners.